Studies have indicated that elevated levels of serum IL-22 and a high presence of IL-22-producing cells infiltrating tumors are unfavorable prognostic indicators for patients with HCC and are strongly associated with reduced overall survival [109,110]. This evidence concerns the gene IL22 and hepatocellular carcinoma.